Biogen, Denali to partner for development of Parkinson's disease Med
The partnership is bound to attract a lot of attention as Parkinson’s, a debilitating degenerative neuro disease h...
Biogen Pays $124 Million to Develop Gene-Based Therapies
On Thursday, Biogen Inc. will enter into the area of eye-disease treatment by paying Applied Genetic Technologies Corp. ...
